Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05398172 · ClinicalTrials.gov registry record · NA
Clinical Evaluation of Fractional Bi-Polar Radio-Frequency for Symptoms of Vulvovaginal Atrophy
A NA study, sponsored by InMode MD.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT05398172 is a NA study that has completed, run by InMode MD. The registered enrollment target is 30 participants.
The verdict
NCT05398172, a NA study, has completed, sponsored by InMode MD.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
Prospective, one arm, baseline-controlled At least 30 healthy adult female volunteers, from 2 investigational sites seeking treatment for Symptoms of Vulvovaginal Atrophy Eligible subjects will receive 3 treatments 4 weeks apart with the MorpheusV Applicator according to the study protocol The subject will return for 3 follow up visits: 3 months follow up (3M FU), 6 months follow up (6M FU), 12months follow up (12M FU) after the treatment. Total expected study duration is approximately 12 months.
Interventions
- DEVICE MorpheusV Applicator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2021-08-10 |
| Est. Completion | 2024-06-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05398172
The ClinicalTrials.gov registry entry for NCT05398172 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is InMode MD, which has 22 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MorpheusV Applicator is the first listed.
NCT05398172 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05398172 about?
NCT05398172 is a clinical study titled "Clinical Evaluation of Fractional Bi-Polar Radio-Frequency for Symptoms of Vulvovaginal Atrophy". Prospective, one arm, baseline-controlled At least 30 healthy adult female volunteers, from 2 investigational sites seeking treatment for Symptoms of Vulvovaginal Atrophy Eligible subjects will receive 3 treatments 4 weeks apart with the MorpheusV Applicator according to the study protocol The subje...
What is the current status of trial NCT05398172?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2021-08-10. Estimated completion is 2024-06-18.
What interventions are being tested in trial NCT05398172?
The interventions under investigation include: MorpheusV Applicator (DEVICE).
Who is sponsoring clinical trial NCT05398172?
This trial is sponsored by InMode MD, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.